Call Us:


Advancing the Future of Cancer Clinical Trial Enrollment


A one-of-a-kind cancer clinical trial matching service with personalized guidance.


At Massive Bio, dedicated patient advocates assist patients in getting the latest in cancer care which is often found in clinical trials.

Many patients don’t know about all the clinical trial options near them and they can also qualify for more than one clinical trial. Going through the process of finding clinical trials that you qualify for and are nearby can feel confusing and overwhelming. When you don’t know what to do or where to turn, that’s when Massive Bio comes in.

We utilize our learning SYNERGY Artificial Intelligence (AI) platform to help match you to clinical trials that cater to your specific cancer type and situation. With over 170 custom clinical algorithms built into platform, we draw on the world’s best clinical research to pair you with the latest clinical trials that offer state-of-the-art therapies not available elsewhere.

We review your case and provide a list of options from the more than 30,000 available clinical trials around the world.

  • You will be registered in SYNERGY-AI, our proprietary Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry platform.
  • You will receive a detailed report of eligible clinical trials powered by a state-of-the-art database, machine learning, and AI, focused on:
    • Novel immunotherapies, cell therapies, and cancer vaccines
    • Promising biomarkers based on your tumor type
    • Targeted drugs based on your cancer biomarkers and genomics
  • You will know all your options for the best clinical trials.
  • You will learn more about cancer research and how to use it to fight your cancer
  • You will have access to the latest treatments and world-class care

For a free clinical trial consultation to discuss your case, fill out the contact form and a Cancer Care Specialist will call you within 24 hours.

    By submitting, you agree to our Terms And Conditions and have read and acknowledged our Privacy Statement.